JUVÉDERM® VOLUX® XC
JUVÉDERM® Volux® XC dermal filler excels at addressing contouring such as the chin and jaw-line.
Unique among the Juvederm® family of dermal fillers, Volux® focuses on facial contours.
The formulation lasts longer than most hyaluronic acid fillers in the skin. Vycross® crosslinking technology extends the longevity of this filler’s results (after full correction) up to 12 months.
Volux® is a crystal-clear gel that is injected using an fine needle. The lidocaine inside the gel improves the comfort of the injection by reducing sensitivity to pain. Besides helping restore volume beneath the surface of different areas of the face without surgery, treatment additionally also boosts the skin’s resilience.
Juvéderm Volux® XC (“Juvéderm Jawline”)
What is JUVÉDERM® VOLUX® XC?
JUVÉDERM® VOLUX® XC is an injectable gel designed to improve jawline definition in patients with moderate to severe loss of jawline definition. Adding volume to improve the shape and structure of the lower face helps provide smooth, long-lasting definition in the jawline for adults over 21 years of age.
How long does JUVÉDERM® VOLUX® XC last?
JUVÉDERM® VOLUX® XC lasts up to 1 year, with optimal treatment.
What are the potential side effects of JUVÉDERM® VOLUX® XC?
Most side effects were mild or moderate in nature with duration of 14 days or less—35% of side effects lasted up to 30 days. The most common side effects were temporary reactions at the treatment site, such as tenderness, lumps/bumps, pain, swelling, firmness, bruising, redness, itching, and discoloration. As with all skin-injection procedures, there is a risk of infection.
How does JUVÉDERM® VOLUX®XC work?
JUVÉDERM® VOLUX® XC is a crystal-clear gel that is injected into the jaw to improve jawline definition. It temporarily adds volume to augment the shape and structure of the lower face and results in improved jawline definition in adults over the age of 21. The lidocaine in the gel improves the comfort of the injection by reducing sensitivity to pain.
WHAT IS HYALURONIC ACID?
Hyaluronic acid, or HA, is a natural substance in the body that strongly binds to water. As a result it delivers volume and added resilience to the skin. Modified HA is the main ingredient behind JUVÉDERM ®. Different formulations have different physical properties. This allows selection of the optimal match for the problem at hand. JUVÉDERM® VOLBELLA® XC is the softest version, Voluma™ the firmest (think chin and cheeks), while VOLLURE® has the most pliability (laugh-lines).
Our practice has educational displays that patients can interact with to experience what these different versions look and feel like.
Treatment as a rule can be done in under 20 minutes. A temporary brief stinging sensation as generally well tolerated. Afterwards side effects can be in the form of tenderness, swelling, firmness, lumps/bumps, bruising, pain, redness, discoloration, and itching. Side effects are transient and mild or moderate in discomfort . They generally last under 30 days. Juvéderm can reversed with Hyaluronidase.
Which Juvéderm® is for you?
A complimentary consultation with Dr. Robben will address your concerns and review the procedure and possible side effects.
There are ways to save on the cost of treatment. For patients who want to keep away their forehead lines, crow’s feet, and other wrinkles we offer long-term cost-savings: the Mind Your Skin Maintenance Program. With injection sessions scheduled at regular intervals, you maximize safe, reliable results to help you keep looking your best. In addition, MindYourSkin and Dr. Robben partner with Allergan, the makers of BOTOX® and Juvederm®.
Go to www.Alle.com and migrate your account (new patients can start one there) that also works for Botox®, Kybella®and Latisse, as well as various in-office treatments such as laser hair removal, microdermabrasion, Ultrashape and more…
IN THE NEWS
COVID-19 update. Delayed dermal filler inflammatory events very rarely occur with both hyaluronic acid and non-hyaluronic acid fillers. Evidence suggests these reactions can be immunologically triggered by viral and bacterial illness, vaccinations such as the influenza vaccine, and dental procedures. These rare adverse events are temporary and respond to treatments such as oral corticosteroids and hyaluronidase, and often resolve without treatment. Given currently available data, patients already treated with dermal fillers should not be discouraged or precluded from receiving vaccines of any kind. Similarly, patients who have had vaccines should not be precluded from receiving dermal fillers in the future. Specifically, with regard to the Moderna mRNA-1273 trial, there were a total of 3 reactions possibly related to dermal fillers out of 15,184 vaccine recipients. It is unknown how many subjects in the trial had previous treatment with dermal fillers.
Check for specials